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ABSTRACT
Evaluation and management of abdominal pathology in
patients with ventricular assist devices is likely to become
increasingly important as the utilization of these devices
expands. Ventricular assist devices represent a class of
intracorporeal or paracorporeal mechanical devices that
augment cardiac output in patients with congestive heart
failure. Patients with ventricular assist devices supporting
both right and left ventricles (biventricular assist devices)
are uniquely challenging to the general surgeon because
these devices restrict direct access to the abdominal cavity
and because of the perioperative implications of biven-
tricular heart failure. We describe herein the first reported
successful laparoscopic cholecystectomy in a patient with
a paracorporeal biventricular assist device. Cholecystec-
tomy was performed in this patient for acute cholecystitis
that occurred while the patient was awaiting heart trans-
plantation. Our results add weight to the small body of
evidence that laparoscopy is well tolerated in ventricular
assist devices patients. The unique aspects of the biventricu-
lar assist device patient make laparoscopic abdominal inter-
vention particularly suitable in this patient population.
Key Words: Ventricular assist device, Laparoscopy, Cho-
lecystectomy.
INTRODUCTION
Ventricular assist devices (VADs) have become an im-
portant modality in the treatment of congestive heart
failure. The most common application of VADs is as a
bridge to transplantation in patients with end-stage
heart failure. Less commonly, VADs can serve as a
bridge to recovery in patients with potentially revers-
ible acute heart failure. Recent studies also support the
use of VADs as destination therapy, in which VADS are
permanently implanted as an alternative to heart trans-
plantation. The expanding application of VADs makes it
increasingly likely that general surgeons will encounter
patients with these devices. We describe herein the
presentation and management of acute cholecystitis in a
patient with VADs supporting both right and left ven-
tricles (BiVAD). This patient ultimately was treated by
laparoscopic cholecystectomy, which has not been pre-
viously reported in a patient with a BiVAD. This article
describes the complexities inherent in diagnosing and
treating abdominal conditions in patients with VADs. A
brief review of VAD technology and abdominal surgery
in VAD patients is also provided.
Several types of VADs are FDA approved for clinical use
in the United States. Devices vary in their biomechani-
cal design, biomaterials, and drive mechanism. The
Thoratec paracorporeal VAD System (Thoratec Corpo-
ration, Pleasonton, CA), which was utilized in our pa-
tient, is a pneumatically driven device that has an ef-
fective stroke volume of 65 mL and can deliver pulsatile
blood flows of 1.3 L/min to 7.2 L/min. This VAD con-
sists of 3 components: a blood pump that acts as a
prosthetic ventricle; 2 cannulae that connect the blood
pump to the heart and great vessels; and a drive console
that powers the pump pneumatically (Figure 1). The
pump is considered paracorporeal because the pump
chamber itself resides outside the body and delivers
flow through transcutaneous cannulae that enter the
body 2 cm to 4 cm below the costal margin. Separate
inflow and outflow cannulae are required for each VAD
device. Thoratec paracorporeal VADs can be used to
support the left ventricle, right ventricle, or both ven-
tricles (LVAD, RVAD, and BiVAD, respectively).
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CASE REPORTMETHODS
A 54-year-old male underwent reoperative coronary artery
bypass grafting and was unable to be weaned from car-
diopulmonary bypass despite maximal inotropic and va-
sopressor support as well as intraaortic balloon pump
counterpulsation. A Thoratec paracorporeal pneumatic
VAD was implanted to support the left ventricle (LVAD),
followed by successful weaning from bypass. Due to pro-
gressive right heart failure, he subsequently required ad-
ditional placement of a Thoratec VAD to support the right
ventricle (RVAD) 48 hours later (Figure 2). His early post-
operative course was remarkable for renal failure, requiring
continuous renal replacement therapy and shock liver. Kid-
ney and liver function returned to normal by 3 weeks post-
operatively, and he was able to tolerate enteral nutrition and
to engage in physical therapy. He was fully anticoagulated
with coumadin (international normalized ratio 2.5 to 3.5) and
aspirin according to a standard protocol.
Fifty-four days after BiVAD placement, the patient devel-
oped right upper quadrant pain, nausea, and vomiting.
Physical examination revealed right upper quadrant ten-
derness in the area of one of the RVAD cannula exit sites.
A computed tomographic (CT) scan of the abdomen was
unremarkable, and an abdominal ultrasound demon-
strated gallstones. Both studies were technically limited
due to the position of the overlying device. On HIDA
scan, the gallbladder was not visualized after 24 hours,
and the diagnosis of acute cholecystitis was made. The
patient had worsening pain despite antibiotics and re-
quired a cholecystectomy. Percutaneous cholecystostomy
was felt to be contraindicated because of the risk of VAD
infection resulting from a percutaneous drain in the vicin-
ity of the RVAD cannula.
In preparation for surgery, anticoagulation was reversed
with fresh frozen plasma. The paracorporeal VAD com-
ponents were wrapped in sterile plastic and draped within
the operative field. Laparoscopic ports were placed in
standard fashion with each of 2 right subcostal ports
placed lateral to the RVAD pump (Figure 1). Pneumo-
peritoneum was maintained by using carbon dioxide at a
maximal pressure of 15 mm Hg. During surgery, stable
LVAD flows of 5 L/min to 6 L/min and RVAD flows of 4
L/min to 5 L/min were maintained with no decrease in
blood pressure or filling pressures.
Intraoperative findings were consistent with acute calcu-
lous cholecystitis. Laparoscopic cholecystectomy was per-
formed, and argon beam coagulation was utilized to con-
trol extensive bleeding from the gallbladder fossa. Total
operating time was 45 minutes. Anticoagulation was with-
held postoperatively, but the international normalized ra-
tio rose to 3.3 and the patient developed postoperative
bleeding requiring relaparoscopy on postoperative day
one. Bleeding at one of the 5-mm port sites was identified
and corrected with suture ligation. The remainder of the
postoperative course was uneventful. The patient under-
went successful BiVAD removal and heart transplantation
after 101 days of VAD support.
Figure 1. Schematic of a Thoratec paracorporeal BiVAD dem-
onstrating side-by-side VADs, each supporting one ventricle.
Port sites for laparoscopic cholecystectomy are indicated (x).
Figure 2. Postoperative appearance of a patient with a Thoratec
paracorporeal BiVAD. Transcutaneous cannulae exit the abdom-
inal wall approximately midway between the sternotomy inci-
sion and umbilicus.
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This represents the first reported laparoscopic cholecys-
tectomy in a patient with a BiVAD. In the current case, a
laparoscopic approach was ideal because of the position-
ing of the BiVAD (Figure 2). Biventricular paracorporeal
devices like the Thoratec device described here obscure
both upper abdominal quadrants and largely preclude
subcostal incisions. A vertical midline laparotomy would
be possible with careful attention to positioning and drap-
ing of the device, but the risk of exposing the pump
components to enteral or infected material and causing
device infection would remain. Laparoscopy, however,
can be performed with minimal disturbance of paracor-
poreal pump devices and little risk of device contamina-
tion. Other potential benefits of laparoscopy including
decreased postoperative pain and decreased wound com-
plications have obvious appeal in this population.
Undertaking abdominal surgery in the VAD patient must
be done with an understanding of VAD position and
function. Paracorporeal devices like the Thoratec VAD
System utilize extraanatomical pumps and trancutaneous
cannulae. In contrast, intracorporeal devices like the
Heartmate (Thoratec Corporation, Pleasanton, CA) or No-
vacor LVAS (World Heart Corporation, Oakland, CA) are
implanted either inside the peritoneal cavity or within the
rectus sheath. Intracorporeal devices rely on transcutane-
ous drive lines for power, but the pump itself and pump
cannulae passing to the mediastinum are contained com-
pletely within the body. Factors that influence the choice
between paracorporeal and intracorporeal devices in-
clude body habitus, the need for univentricular versus
biventricular support, expected duration of support, and
surgeon preference. Totally implantable devices that have
no external components are under investigation. A com-
parison of commonly utilized VADs that are FDA-ap-
proved for bridge-to-transplant, bridge-to-recovery, or
destination therapy is provided in Table 1. With any VAD,
contamination of the device, drive lines, or pump pocket
must be avoided, as infection is the leading cause of
morbidity and mortality in VAD patients. In addition, if the
cannulae cross the diaphragm inside the peritoneal cavity,
risk is present of pneumopericardium or tension pneumo-
thorax during abdominal insufflation.
Table 1.
FDA-Approved Ventricular Assist Devices
Device Potential Support
Options†
Position
Thoratec VAD System* RVAD, LVAD, or BiVAD Paracorporeal
Thoratec IVAD* RVAD, LVAD, or BiVAD Intracorporeal
Heartmate LVAS* LVAD Intracorporeal
Novacor LVAS† LVAD Intracorporeal
Abiomed BVS 5000‡ LVAD, RVAD, or BiVAD Paracorporeal
*Thoratec Corporation, Pleasanton, California.
†RVADright ventricular assist device; LVADleft ventricular
assist device; BiVADbiventricular assist device.
‡Abiomed Corporation, Danvers, Massachusetts.
Table 2.
Reported Series of Abdominal Surgery in Patients With Ventricular Assist Devices
Study No. of Pts. Type of Device* Type of Surgery (n) Complications (n)
Votapka1 1994 3 PC LVAD Open cholecystectomy (2),
Laparoscopic cholecystectomy (1)
Bleeding (1/3), Early death (1/3)
Goldstein2 1995 1 PC LVAD Plication gastric ulcer Hypotension
Prendergast3 1996 1 PC BiVAD Diagnostic laparoscopy None†
Aleksic4 1998 1 IC LVAD Laparotomy, small bowel
resection
None
Schmid5 2001 11 IC LVAD Open cholecystectomy alone (4)
or combined with bowel
resection or cecostomy (3)
Open ileostomy or cecostomy (3)
Open bowel resection (1)
Bleeding (6/11)
Nissen 2004 1 PC BiVAD Laparoscopic cholecystectomy Bleeding
*PCparacorporeal; ICintracorporeal; LVADleft ventricular assist device; BiVADbiventricular assist device.
†Support withdrawn and patient died shortly after surgery.
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inal surgery in patients with VADs.1–5 These reports are
summarized in Table 2. The majority of these cases were
open explorations for complications directly attributable to
cardiopulmonary bypass or splanchnic ischemia. The most
common reported postoperative surgical complication in
these collective reports was bleeding, similar to that seen in
the patient described herein. This risk arises from the re-
quirement for anticoagulation to prevent VAD-related throm-
boembolic events. Among these reports, only 2 are prior
reports of laparoscopy in VAD patients. Votapka and others1
reported successful laparoscopic cholecystectomy in a pa-
tient with univentricular support, and Prendergast and oth-
ers3 reported the use of brief diagnostic laparoscopy in a
moribund patient with BiVAD support. The current report
demonstrates that more prolonged therapeutic laparoscopy
is also possible in the BiVAD patient. Similar to these prior
reports, we found that laparoscopy was well tolerated and
that abdominal insufflation did not produce hemodynamic
instability.
Evaluation of the abdomen in the VAD patient should
consider the same differential diagnosis as any patient
previously undergoing cardiopulmonary bypass, in-
cluding pancreatitis, acute cholecystitis, ischemic
bowel, perforated ulcer, and diverticulitus. In addition,
transcutaneous cannulas and drivelines may produce
musculoskeletal symptoms that may mimic intraab-
dominal pathology. Standard imaging modalities, such
as CT scan and ultrasound, may be nondiagnostic in the
VAD patient because of interference by overlying de-
vices. Our report and the few prior reports of laparos-
copy in VAD patients support the expanded use of
diagnostic and therapeutic laparoscopy in this patient
group. Careful attention to device location and func-
tion, perioperative anticoagulation and postoperative
bleeding risk is paramount in any anticipated abdomi-
nal intervention in the VAD patient.
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